HBSP (USA)
-
CIBA-GEIGY Pharmaceuticals: Pharma International (Spanish version)
Smith, N. Craig; Quelch, John A.Case HBS-519S11MarketingExamines the decision by Pharma International on whether to launch an antimalarial product in Nigeria and, if so, how that should be implemented. Involves commercial, ethical, and policy considerations. Rich in situation assessment data, the case refers to criticism of pharmaceutical marketing practices in the Third World and CIBA-GEIGY's Servipharm initiative, one response to this problem.Starting at €8.20
-
Fleet Management? (Spanish version)
Casadesus-Masanell, Ramon; Gassmann, Oliver; Sauer, RomanCase HBS-718S24StrategyThis case explores the strategic decision-making process of premium power tools manufacturer Hilti in 1999, when the company was considering implementing a fleet management system in the construction industry. Fleet management would involve a shift from selling power tools to leasing them as a service. For Hilti, it represented an entirely new business model, which would substantially differentiate the company from its competitors. While fleet ma...Starting at €8.20
-
Portfolio Planning at CIBA-GEIGY and the Newport Investment Proposal (Spanish version)
Collis, David J.; Johnson, ElizabethCase HBS-719S09StrategyCovers the history of portfolio planning at CIBA-GEIGY, a leading Swiss chemical and pharmaceutical company, beginning with the introduction of the process in the mid-1980s. The discussion extends to the application of portfolio planning techniques to a specific investment proposal: the comprehensive modernization of a plant dedicated to the production of high-quality specialty pigments.Starting at €8.20
-
Hilti Fleet Management (B): Towards a New Business Model (Spanish Version)
Casadesus-Masanell, Ramon; Gassmann, Oliver; Sauer, RomanCase HBS-719S19StrategyLos tacleadas (B) de casos el proceso de implementación y la escala de gestión de flotas en los últimos años. Por último, el caso explora los desafíos actuales que enfrenta el IMC.Starting at €5.74
-
Andrew Ryan at VC Brakes (Spanish version)
Cespedes, Frank V.; Yong, SunruCase HBS-915S01Leadership and People ManagementAn aftermarket brake component manufacturer, VC Brakes, is bought out by a global automotive parts corporation after the 2008 financial crisis. Unlike its previous parent company, the new owner attempts to change VC Brakes' autocratic management style and finger-pointing culture with a Total Quality Management (TQM) program. Andrew Ryan is a senior manager at VC Brakes. With the guidance of a strong mentor and a reputation as a successful change ...Starting at €8.20
-
Netflix (Spanish version)
Shih, Willy; Kaufman, Stephen P.; Spinola, DavidCase HBS-608S26Strategyvideo-on-demand. How should Netflix respond?Starting at €8.20
-
Novartis: el liderazgo de una empresa global
George, William W.; Palepu, Krishna G.; Knoop, Carin-IsabelCase HBS-418S09StrategyNovartis, empresa de salud más importantes del mundo, se formó en 1996 de la fusión de dos compañías farmacéuticas muy diferente, de nivel medio con sede en Suiza. El caso describe la evolución de la compañía durante los últimos 17 años, ya que se transformó en una empresa verdaderamente global, con 127.000 empleados de 153 nacionalidades en 140 países y generando $ 56,7 mil millones en 2012 ingresos y $ 9.6 mil millones en ingresos netos, por lo...Starting at €8.20
-
Novartis: Leading a Global Enterprise
George, William W.; Palepu, Krishna G.; Knoop, Carin-IsabelCase HBS-413096-ENovartis, the world's leading healthcare company, was formed in 1996 out of a merger of two very different, mid-tier Switzerland-based pharma companies. The case traces the company's evolution over the past 17 years, as it transformed into a truly global enterprise with 127,000 employees of 153 nationalities in 140 countries generating $56.7 billion in 2012 revenues and $9.6 billion in net income, making the firm one of the world's largest and mo...Starting at €8.20
-
Innovation and Growth at Actelion Ltd.
Pisano, Gary P.; Beyersdorfer, Daniela; Dittrich, RuthCase HBS-611065-ELeadership and People ManagementIn late 2010, Jean-Paul Clozel, CEO of the Swiss biotech pharmaceuticals firm Actelion, looks back on a successful decade. The small venture that he had started with a few of his scientist colleagues in the late 1990s to discover novel medicine in a research-driven organisation had grown into one of Europe's largest biotech firms by revenues. Their success was mainly founded on their orphan indication drug Tracleer, which Actelion sold and market...Starting at €8.20
-
Nestl : Nutrition, Health, and Wellness
Bell, David E.; McLoughlin, Damien P.; Kindred, NatalieCase HBS-517052-EMarketingStarting at €8.20